Hematological Immune-Related Adverse Events After Treatment With Immune Checkpoint Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Hematological Immune-Related Adverse Events After Treatment With Immune Checkpoint Inhibitors
Eur. J. Cancer 2021 Apr 01;147(xx)170-181, R Kramer, A Zaremba, A Moreira, S Ugurel, DB Johnson, JC Hassel, M Salzmann, A Gesierich, A Weppler, L Spain, C Loquai, M Dudda, C Pföhler, A Hepner, GV Long, AM Menzies, MS Carlino, MM Sachse, C Lebbé, B Baroudjian, T Enokida, M Tahara, M Schlaak, K Hayani, PJ Bröckelmann, F Meier, L Reinhardt, P Friedlander, T Eigentler, KC Kähler, C Berking, L Zimmer, L HeinzerlingFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.